Literature DB >> 19021285

Stent fractures in congenital heart disease.

John P Breinholt1, Alan W Nugent, Mark A Law, Henri Justino, Charles E Mullins, Frank F Ing.   

Abstract

OBJECTIVE: To describe incidence, characteristics, predictive factors, and sequelae of stent fractures in congenital heart disease.
BACKGROUND: Stent fracture in congenital heart disease patients is rarely reported.
METHODS: Patients with stents implanted from 1990 to 2006, with subsequent fluoroscopy were enrolled. Information obtained included: stent type, location, balloon diameter, and residual narrowing. Fracture characteristics, radiographic appearance, and clinical sequelae were also obtained in those with fractures identified.
RESULTS: : Two hundred and sixty-five patients (583 stents) had fluoroscopy 4.2 +/- 3.3 years after stent implantation. The majority of stents (395, 67.7%) were placed in a pulmonary artery (PA) or its branches. Sixteen stents (2.7%) were placed in a right ventricle to pulmonary artery (RV-PA) conduit. Fourteen fractures (2.4%) were identified 5.0 +/- 3.2 years after implantation: RV-PA conduit 4/16, proximal right PA 4/135, proximal left PA 6/184 (P = 0.003). Identification was primarily made on lateral fluoroscopy. Review of chest radiographs demonstrated fractures in only 71%. In fractured PA stents, five were redilated and three had additional stents placed. Of the four conduit stent fractures: one underwent redilation, one had embolized segments, and one was reinforced with a second stent that also fractured and embolized a segment during redilation at a later catheterization. All fractures were asymptomatic.
CONCLUSIONS: With the exception of RV-PA conduit stents, fracture is rare and asymptomatic. PA stent fractures occurred in 2.5% and did not embolize, whereas RV-PA conduit stent fractures were significantly more common and may embolize. Copyright 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 19021285     DOI: 10.1002/ccd.21742

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  8 in total

1.  Effectiveness and safety of percutaneous transcatheter implantation of pulmonary arterial stent in congenital heart disease.

Authors:  Hong Ki Ko; Young-Hwue Kim; Jeong Jin Yu; Jae-Kon Ko; In-Sook Park; Dong-Man Seo; Tae-Jin Yun; Jeong-Jun Park; Wan Sook Jang
Journal:  Korean Circ J       Date:  2012-01-31       Impact factor: 3.243

Review 2.  Compression, distortion and dislodgement of large caliber stents in congenital heart defects caused by cardiopulmonary resuscitation: a case series and review of the literature.

Authors:  Nikolaus A Haas; Christoph M Happel; Smita Jategaonkar; Axel Moysich; Andreas Hanslik; Deniz Kececioglu; Eugen Sandica; Kai Thorsten Laser
Journal:  Clin Res Cardiol       Date:  2014-04-04       Impact factor: 5.460

3.  Medium and long-term outcomes after bilateral pulmonary artery stenting in children and adults with congenital heart disease.

Authors:  Ismael Gonzalez; Damien Kenny; Shari Slyder; Ziyad M Hijazi
Journal:  Pediatr Cardiol       Date:  2012-07-28       Impact factor: 1.655

4.  The role of stents in the treatment of congenital heart disease: Current status and future perspectives.

Authors:  Bjoern Peters; Peter Ewert; Felix Berger
Journal:  Ann Pediatr Cardiol       Date:  2009-01

5.  Postmarketing trials and pediatric device approvals.

Authors:  Thomas J Hwang; Aaron S Kesselheim; Florence T Bourgeois
Journal:  Pediatrics       Date:  2014-04-14       Impact factor: 7.124

6.  Serial Versus Direct Dilation of Small Diameter Stents Results in a More Predictable and Complete Intentional Transcatheter Stent Fracture: A PICES Bench Testing Study.

Authors:  Matthew A Crystal; Gareth J Morgan; Saar Danon; Robert G Gray; Daniel H Gruenstein; Brent M Gordon; Bryan H Goldstein
Journal:  Pediatr Cardiol       Date:  2017-10-04       Impact factor: 1.655

7.  Pulmonary artery stents-still "off label".

Authors:  Seong-Ho Kim
Journal:  Korean Circ J       Date:  2012-01-31       Impact factor: 3.243

8.  Outcomes Associated with the Off-label Use of Medical Devices in Congenital Heart Disease at a Single Institute.

Authors:  Young Hwa Kong; Jinyoung Song; Jun Huh; I-Seok Kang
Journal:  Korean Circ J       Date:  2017-07-27       Impact factor: 3.243

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.